The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of black foreign material within the infusion set was confirmed and the cause appeared to be manufacturing-related.The product returned for evaluation was one 22ga x 0.75¿ huber plus safety infusion set.The sample was received in its original sealed package.The package seal was complete and unremarkable.Two pieces of black material were observed within the sealed package.Microscopic inspection of the sample confirmed the presence of material within the sealed package.The objects appeared consistent with fragments of polymer type material.The sealed state of the packaging indicated that the black material was deposited within the packaging during device assembly/packaging.Photographs of the sample have been forwarded to the manufacturing site for further evaluation.
|